絞り込み

16545

広告

「中国版GPS」衛星打ち上げ 成功の様子を公開

中国は19日、「中国版GPS」とも呼ばれるシステムに利用する衛星の打ち上げに成功し、その様子を一部の外国メディアに公開しました。宇宙分野の技術力の高まりをアピー...

  1. 【要指導・一般薬部会】鼻過敏症治療薬「フ...
  2. 【要指導・一般薬部会】鼻過敏症治療薬「フ...
  3. 【中国四国支部学術大会で報告】疑義照会簡...
  4. 12月13~14日に「第3回DIA再生医...

ニュース一覧

MTOR pathway in focal cortical dysplasia type 2: What do we know?

著者 Majolo F , Marinowic DR , Machado DC , Da Costa JC
Epilepsy Behav.2018 Jun 23 ; 85():157-163.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (21view , 0users)

Full Text Sources

Miscellaneous

Focal cortical dysplasia (FCD) is the most commonly encountered developmental malformation that causes refractory epilepsy. Focal cortical dysplasia type 2 is one of the most usual neuropathological findings in tissues resected therapeutically from patients with drug-resistant epilepsy. Unlike other types of FCD, it is characterized by laminar disorganization and dysplastic neurons, which compromise the organization of the six histologically known layers in the cortex; the morphology and/or cell location can also be altered. A comprehensive review about the pathogenesis of this disease is important because of the necessity to update the results reported over the past years. Here, we present an updated review through Pubmed about the mammalian target of rapamycin (MTOR) pathway in FCD type 2. A wide variety of aspects was covered in 44 articles related to molecular and cellular biology, including experiments in animal and human models. The first publications appeared in 2004, but there is still a lack of studies specifically for one type of FCD. With the advancement of techniques and greater access to molecular and cellular experiments, such as induced pluripotent stem cells (iPSCs) and organoids, it is believed that the trend is increasing the number of publications contributing to the achievement of new discoveries.
PMID: 29945038 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード